TNF Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)23holders +4
7new positions
3sold out
$1.85avg. 13F price*
At the end of Q2 2024, 23 institutions reported holding TNF Pharmaceuticals Inc. in their 13F filings, up 4 from Q1 2024. 7 opened new positions and 3 sold out. The largest holders were UBS Group AG ($29K), Geode Capital Management, LLC ($27K) and Vanguard Group Inc. ($26K).
- Company
- TNF Pharmaceuticals Inc.
- Filed as
- MYMD PHARMACEUTICALS INC (Q2 2024)
- CUSIP
- 62856X201
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $49K |
| Exits | 3 | $1.3M |
All 13F filers, Q1 2024 → Q2 2024: 40,038 shares bought and 895,866 shares sold, net −855,828 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| UBS Group AG | 0.00% | Add +682.5% | 15,822 | $29K |
| Geode Capital Management, LLC | 0.00% | New | 14,410 | $27K |
| Vanguard Group Inc. | 0.00% | Reduce -54.3% | 13,999 | $26K |
| Virtu Financial LLC | 0.00% | New | 11,688 | $22K |
| BlackRock Inc. | 0.00% | Reduce -44.1% | 3,803 | $7K |
| Parallel Advisors, LLC | 0.00% | No change | 838 | $2K |
| Group One Trading LLC | 0.00% | Reduce -15.7% | 387 | $712 |
| Osaic Holdings, Inc. | 0.00% | No change | 266 | $487 |
| Morgan Stanley | 0.00% | Reduce -13.8% | 193 | $355 |
| Wells Fargo & Company | 0.00% | Reduce -5.7% | 167 | $307 |
| Sandy Spring Bank | 0.00% | No change | 116 | $214 |
| Harbor Investment Advisory, LLC | 0.00% | No change | 90 | $166 |
| Redwood Wealth Management Group, LLC | 0.00% | New | 50 | $92 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 39 | $72 |
| NFSG Corp | 0.00% | No change | 34 | $63 |
| Arvest Investments, Inc. | 0.00% | No change | 34 | $62 |
| Mather Group, Llc. | 0.00% | New | 17 | $41 |
| St. Johns Investment Management Company, LLC | 0.00% | New | 18 | $33 |
| Bank of America Corp. | 0.00% | Add +1500.0% | 16 | $30 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $6 |
| Anchor Investment Management, LLC | 0.00% | New | 1 | $2 |
| Cornerstone Planning Group LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -49.4% | 40 | $0 |
"% of holder's portfolio" is TNF PHARMACEUTICALS INC's weight in each manager's 13F, not the share of TNF Pharmaceuticals Inc. the manager owns.